Follicular Helper T Cells in Peyer's Patches and Galactose-Deficient Iga1 Contribute to Iga Nephropathy

被引:2
|
作者
Huang, Yuye [1 ]
Sun, Xunling [1 ]
Nie, Guoming [1 ]
Xu, Hongtao [1 ]
Zou, Minshu [1 ]
机构
[1] Gen Hosp Cent Theater Command, Dept Pediat, 627, Wuluo Rd, Wuhan 430030, Hubei, Peoples R China
关键词
IgA nephropathy; Peyer's patches; T follicular helper cell; CD4 T Cells; Interleukin-21; Galactose-deficient IgA1; PLASMA-CELLS; B-CELLS; DIFFERENTIATION;
D O I
10.2174/1566524023666230720112215
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Common primary glomerulonephritis with aberrant mucosal immunity is IgA nephropathy (IgAN). T follicular helper (TFH) cells are essential in regulating B cell differentiation. Peyer's patches (PPs) are the main site where IgA+ plasmablasts differentiate. Objective: Our study aimed to investigate the TFH cell's potential contribution to the etiology of IgA nephropathy. Methods: In PPs from IgAN mouse models, the ratio of the TFH cell, B220+IgA+, B220+IgM+, and B220-IgA+ lymphocytes were assessed. Then, we used Western blot to assess the expression of Bcl-6, Blimp- 1, and IL-21 proteins in PPs and used RTPCR to assess the expression of IL-21 and TGF-beta 1 mRNA. TFH cells coculture with spleen cells to measure the degree of IL-21 and the ratio of activation marker CD69 on the TFH cells. Naive B cells (CD27(-)IgD(+)) from children suffering from IgAN were cultured with TFH cell-related cytokines. The supernatant was detected to assess the excretion of galactose-deficient IgA1 (Gd-IgA1). Results: IgAN mice developed noticeably increased degrees of IL-21 and CD69 on TFH cells than controls did, as well as higher percentages of B220+IgA+, B220+IgM+, B220+IgA+, TGF- beta 1, and IL-21 mRNA and Bcl-6, IL-21 proteins in PPs. The Gd-IgA1 level in the supernatant and IgAN- positive children's serum were noticeably higher than those of the healthy controls (P < 0.05). PPs provide the microenvironment to induce the production of IgA-secreting plasmablasts. Conclusion: TFH cells may be a key moderator to induce B cell differentiation into IgAsecreting plasmablasts and produce Gd-IgA1, which plays a significant part in IgAN's pathogenesis. It could be a new therapeutic target in the future.
引用
收藏
页码:1033 / 1044
页数:12
相关论文
共 50 条
  • [21] Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease
    Reily, Colin
    Ueda, Hiroyuki
    Huang, Zhi-Qiang
    Mestecky, Jiri
    Julian, Bruce A.
    Willey, Christopher D.
    Novak, Jan
    JOURNAL OF IMMUNOLOGY RESEARCH, 2014, 2014
  • [22] Galactose-Deficient IgA1 in African Americans with IgA Nephropathy: Serum Levels and Heritability
    Hastings, M. Colleen
    Moldoveanu, Zina
    Julian, Bruce A.
    Novak, Jan
    Sanders, John T.
    McGlothan, Kim R.
    Gharavi, Ali G.
    Wyatt, Robert J.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (11): : 2069 - 2074
  • [23] Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1
    Ebefors, Kerstin
    Liu, Peidi
    Lassen, Emelie
    Elvin, Johannes
    Candemark, Emma
    Levan, Kristina
    Haraldsson, Borje
    Nystrom, Jenny
    BMC NEPHROLOGY, 2016, 17
  • [24] Somatic Mutations Modulate Autoantibodies against Galactose-Deficient IgA1 in IgA Nephropathy
    Huang, Zhi Qiang
    Raska, Milan
    Stewart, Tyler J.
    Reily, Colin
    King, R. Glenn
    Crossman, David K.
    Crowley, Michael R.
    Hargett, Audra
    Zhang, Zhixin
    Suzuki, Hitoshi
    Hall, Stacy
    Wyatt, Robert J.
    Julian, Bruce A.
    Renfrow, Matthew B.
    Gharavi, Ali G.
    Novak, Jan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (11): : 3278 - 3284
  • [25] Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels
    Moldoveanu, Z.
    Wyatt, R. J.
    Lee, J. Y.
    Tomana, M.
    Julian, B. A.
    Mestecky, J.
    Huang, W-Q
    Anreddy, S. R.
    Hall, S.
    Hastings, M. C.
    Lau, K. K.
    Cook, W. J.
    Novak, J.
    KIDNEY INTERNATIONAL, 2007, 71 (11) : 1148 - 1154
  • [26] Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy
    Wada, Yukihiro
    Matsumoto, Kei
    Suzuki, Taihei
    Saito, Tomohiro
    Kanazawa, Nobuhiro
    Tachibana, Shohei
    Iseri, Ken
    Sugiyama, Motonori
    Iyoda, Masayuki
    Shibata, Takanori
    PLOS ONE, 2018, 13 (11):
  • [27] CLINICAL SIGNIFICANCE OF SERUM AND MESANGIAL GALACTOSE-DEFICIENT IGA1 IN PATIENTS WITH IGA NEPHROPATHY
    Wada, Yukihiro
    Matsumoto, Kei
    Suzuki, Taihei
    Saito, Tomohiro
    Kanazawa, Nobuhiro
    Tachibana, Shohei
    Fukuda, Kei
    Iseri, Ken
    Iyoda, Masayuki
    Shibata, Takanori
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [28] Serum Galactose-Deficient IgA1 Level Is Not Associated with Proteinuria in Children with IgA Nephropathy
    Hastings, M. Colleen
    Afshan, Sabahat
    Sanders, John T.
    Kane, Oulimata
    Eison, T. Matthew
    Lau, Keith K.
    Moldoveanu, Zina
    Julian, Bruce A.
    Novak, Jan
    Wyatt, Robert J.
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2012, 2012
  • [29] Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1
    Kerstin Ebefors
    Peidi Liu
    Emelie Lassén
    Johannes Elvin
    Emma Candemark
    Kristina Levan
    Börje Haraldsson
    Jenny Nyström
    BMC Nephrology, 17
  • [30] Serum levels of galactose-deficient IgA1 in Chinese children with IgA nephropathy, IgA vasculitis with nephritis, and IgA vasculitis
    Mengmeng Tang
    Xue Zhang
    Xueqian Li
    Lei Lei
    Hejia Zhang
    Chen Ling
    Jie Ni
    Jicheng Lv
    Xiaorong Liu
    Xiangmei Chen
    Clinical and Experimental Nephrology, 2021, 25 : 37 - 43